Overview
This is so much more than a meeting. It’s a community.
See what the community has to share about what makes this conference unique. Read the Testimonials.
The only event developed by QPPVs for QPPVs, now in its 11th year, the network at the QPPV Forum continues to grow. This year’s forum objectives build on past successes and have been shaped by valuable feedback provided by participants of the past ten meetings.
What can you expect by joining this community in 2017?
- Build relationships with fellow QPPVs
- Reconnect with colleagues and meet regulators
- Hear the latest updates and hot topics relating to the role of the QPPV
- Explore long term PV visions, future directions of the ‘PV world’, and potential impact on the role of QPPV
- Learn from and share experience and ideas with like-minded QPPVs in a neutral environment
- Better understand regulatory and inspectorate expectations of the QPPV
- Identify the expanded expectations of the role in the context of the new regulatory framework and transparency initiatives
Over time, one of the key successes of the Forum has been the ability to secure continuing support and involvement of key regulators. Sessions have been open and interactive with attendees appreciating opportunities to raise challenging issues in an informal environment. This QPPV Forum aims to continue to attract such key speakers and encourage open debate.
HIGHLIGHTS - NETWORKING DINNER
The Networking (Buffet) Dinner will start at 18:30h at the:
Crowne Plaza London - Docklands
Royal Victoria Dock
Western Gateway
London, E16 1AL
T: + 44-20-70552000
Dress code: business casual
Who should attend?
- EU QPPVs and Deputies (present or aspiring), regardless of company size
- Pharmacovigilance Regulators and Inspectors
- CRO and Consultants providing QPPV Services
- National Responsible Persons for Pharmacovigilance
- Quality Management Personnel
- Heads of Pharmacovigilance
- Other stakeholders supporting the EU QPPV
Program Committee
-
Peter De Veene, MD • Head Global Patient Safety
AB Science, Belgium -
Elspeth McIntosh, MBA, RN • Director
Castle Pharmacovigilance Ltd, United Kingdom -
Margaret Anne Walters • Deputy EU Qualified Person for Pharmacovigilance
Merck, Sharp & Dohme Ltd, United Kingdom -
Michael Richardson, MD, FFPM, FRCP • Senior Vice President, WorldWide Patient Safety
Bristol-Myers Squibb, United Kingdom -
Brian Edwards, DrMed • Managing Director
Husoteria Ltd, United Kingdom -
Barbara De Bernardi, MD • EUQPPV Vice President - Head of Global QPPV Office
Pfizer S.r.l., Italy -
Vicki Edwards, RPh • Vice President, Pharmacovigilance Excellence and International QPPV
AbbVie, Inc., United Kingdom -
Winrich Rauschning, DrMed, MD, MBA • QPPV
Biolitec Pharma, Germany -
Doris Irene Stenver, MD, MPA • Independent Pharmacovigilance Adviser
Unique Advice, Denmark
